SU1628293A1 - Method of purification of human immunoglobulin antitetanus preparation - Google Patents

Method of purification of human immunoglobulin antitetanus preparation

Info

Publication number
SU1628293A1
SU1628293A1 SU4607839/14A SU4607839A SU1628293A1 SU 1628293 A1 SU1628293 A1 SU 1628293A1 SU 4607839/14 A SU4607839/14 A SU 4607839/14A SU 4607839 A SU4607839 A SU 4607839A SU 1628293 A1 SU1628293 A1 SU 1628293A1
Authority
SU
USSR - Soviet Union
Prior art keywords
antitetanus
preparation
purification
human immunoglobulin
pepsin
Prior art date
Application number
SU4607839/14A
Other languages
Russian (ru)
Inventor
В.С. Сапожникова
И.М. Думкин
Original Assignee
Кировский научно-исследовательский институт гематологии и переливания крови
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кировский научно-исследовательский институт гематологии и переливания крови filed Critical Кировский научно-исследовательский институт гематологии и переливания крови
Priority to SU4607839/14A priority Critical patent/SU1628293A1/en
Application granted granted Critical
Publication of SU1628293A1 publication Critical patent/SU1628293A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

FIELD: medicine. SUBSTANCE: antitetanus immunoglobulin for intramuscular administration is treated with lyophilized pepsin in order to decrease anticomplementary activity following by adsorption of residual pepsin with ammonium hydroxide and pH adjusting of the end product up to values. EFFECT: enlarged spectrum of preparation due to intravenous administration route. 1 tbl
SU4607839/14A 1988-11-23 1988-11-23 Method of purification of human immunoglobulin antitetanus preparation SU1628293A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4607839/14A SU1628293A1 (en) 1988-11-23 1988-11-23 Method of purification of human immunoglobulin antitetanus preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4607839/14A SU1628293A1 (en) 1988-11-23 1988-11-23 Method of purification of human immunoglobulin antitetanus preparation

Publications (1)

Publication Number Publication Date
SU1628293A1 true SU1628293A1 (en) 1994-02-28

Family

ID=60521462

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4607839/14A SU1628293A1 (en) 1988-11-23 1988-11-23 Method of purification of human immunoglobulin antitetanus preparation

Country Status (1)

Country Link
SU (1) SU1628293A1 (en)

Similar Documents

Publication Publication Date Title
EP0261224A4 (en) Synthetic htlv-iii peptides, compositions and uses thereof.
GR3031691T3 (en) Composition and method for preventing and treating inflammation with immunoglobulin a
EP0219524A1 (en) Treatment of adult respiratory distress syndrome.
DK168790D0 (en)
GB8824869D0 (en) Synthetic antibody
CA2093233C (en) Method of administering amiloride
ES2002083A6 (en) Pyroglutamide derivatives
ZA851959B (en) Process for the microbiological preparation of l-carnitine
AU2456888A (en) Monoclonal antibodies specific for HIV and hybridomas for their production
ES8705230A1 (en) Process for preparing gamma-globulins supplied by intravenous administration and gamma-globulins obtained.
TW259710B (en)
SU1628293A1 (en) Method of purification of human immunoglobulin antitetanus preparation
SE8401664D0 (en) PROCEDURE FOR PURIFYING TYLOSIN
GR3036827T3 (en) Method and composition for the treatment of hair loss.
IL78455A0 (en) Method for purifying interferon and composition of matter produced thereby
IL105498A0 (en) Pharmaceutical composition containing ribonucleotide polymerase
GB1229988A (en)
HU900525D0 (en) Process for the production of medical preparations for treating endotoxinemy
Meisel et al. Efficacy of ciprofloxacin in bacterial infections of the skin.
EP0192222A3 (en) Agent for preventing, decreasing or retarding the protein decomposition in the human or animal digestive tract, and process for its production
AU4259193A (en) Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
SU1732518A1 (en) Method of immunoglobulin m preparing
UA14449A1 (en) Process for preparation of pantocrine
HK1013296A1 (en) Analogs of thymosin alpha 1
MY104932A (en) Immunomodulatory azaspiranes